NYSE
BSX

Boston Scientific Corp

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Boston Scientific Corp Stock Price

Vitals

Today's Low:
$41.9200
Today's High:
$43.7250
Open Price:
$42.5300
52W Low:
$34.98
52W High:
$47.5
Prev. Close:
$42.7600
Volume:
12423964

Company Statistics

Market Cap.:
$60.027 billion
Book Value:
12.06
Revenue TTM:
$12.567 billion
Operating Margin TTM:
17.5%
Gross Profit TTM:
$8.241 billion
Gross Profit TTM:
$8.241 billion
Profit Margin:
5.2%
Return on Assets TTM:
4.19%
Return on Equity TTM:
0%

Company Profile

Boston Scientific Corp had its IPO on 1992-05-19 under the ticker symbol BSX.

The company operates in the LIFE SCIENCES sector and SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry. Boston Scientific Corp has a staff strength of 0 employees.

Stock update

Shares of Boston Scientific Corp opened at $42.53 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $41.92 - $43.73, and closed at $41.93.

This is a -1.94% slip from the previous day's closing price.

A total volume of 12,423,964 shares were traded at the close of the day’s session.

In the last one week, shares of Boston Scientific Corp have increased by +2.27%.

Boston Scientific Corp's Key Ratios

Boston Scientific Corp has a market cap of $60.027 billion, indicating a price to book ratio of 3.548 and a price to sales ratio of 4.777.

In the last 12-months Boston Scientific Corp’s revenue was $12.567 billion with a gross profit of $8.241 billion and an EBITDA of $3.343 billion. The EBITDA ratio measures Boston Scientific Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Boston Scientific Corp’s operating margin was 17.5% while its return on assets stood at 4.19% with a return of equity of 0%.

In Q3, Boston Scientific Corp’s quarterly earnings growth was a negative -57.1% while revenue growth was a positive 8.1%.

Boston Scientific Corp’s PE and PEG Ratio

Forward PE
21.98
Trailing PE
102.27
PEG
2.294

Its diluted EPS in the last 12-months stands at $0.41 per share while it has a forward price to earnings multiple of 21.98 and a PEG multiple of 2.294. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Boston Scientific Corp’s profitability.

Boston Scientific Corp stock is trading at a EV to sales ratio of 5.59 and a EV to EBITDA ratio of 32.64. Its price to sales ratio in the trailing 12-months stood at 4.777.

Boston Scientific Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Boston Scientific Corp ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Boston Scientific Corp ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Boston Scientific Corp’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Boston Scientific Corp's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Boston Scientific Corp paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$41.93
52-Week High
$47.5
52-Week Low
$34.98
Analyst Target Price
$48.95

Boston Scientific Corp stock is currently trading at $41.93 per share. It touched a 52-week high of $47.5 and a 52-week low of $47.5. Analysts tracking the stock have a 12-month average target price of $48.95.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Boston Scientific Corp

The stock symbol (also called stock or share ticker) of Boston Scientific Corp is BSX

The IPO of Boston Scientific Corp took place on 1992-05-19

Similar Industry Stocks (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS)

Last Price
Chg
Chg%
$2.33
-0.01
-0.43%
Brainsway Ltd (BWAY)
$3.54
0.03
+0.85%
$66.2
-1.96
-2.88%
$66.41
-2.62
-3.8%
$211.97
-8.12
-3.69%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Address

300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, US